Novare Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Novare Capital Management's AMGN Position: Q2 2026 in Review
Novare Capital Management reduced its Amgen (AMGN) stake by 1.1% in Q2 2026, selling an estimated $5.82K and leaving 1,559 shares worth $564K. The position accounts for 0.04% of the portfolio, ranked #141.
Novare Capital Management first reported a position in AMGN in Q3 2021 and has held it in 10 quarters since. 3,156 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Novare Capital Management held 1,559 shares of Amgen worth $564K as of Q2 2026.
- Novare Capital Management sold 17 Amgen shares in Q2 2026, an estimated $5.82K.
- Amgen made up 0.04% of Novare Capital Management's portfolio in Q2 2026, its #141 holding.
- Novare Capital Management first reported a position in Amgen in Q3 2021 and has held it in 10 quarters since.
- 3,156 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Novare Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.